In contrast, DCF oxidation (Fig
As with any injectable therapy, personalized patient assessment and ongoing monitoring are essential for maximizing benefits and minimizing risk
But GLP-1 agonists, like liraglutide and possibly even its longer-lasting relative semaglutide, may prove to be a promising route for future migraine treatments
Phase 2 initiated June 2025
De forma grfica, necesitamos con urgencia invertir la pirmide actual de evidencia, pasar de las posibilidades a las certezas, y esto difcilmente suceder sin financiacin y apoyo coordinado de la industria, las instituciones acadmicas y las sociedades cientficas para desarrollar estudios multicntricos con grupos de control (Figura 2)
Refrigerate immediately and use within 28 days